Healthcare ETFs to Buy as JNJ Beats the Market With a 25% YTD Surge
Johnson & Johnson JNJ, a healthcare behemoth with a market cap exceeding $600 billion and a portfolio spanning pharmaceuticals and medical devices, has delivered a stellar year-to-date surge of approximately 24.5%. This performance notably outpaces the S&P 500's roughly 10% rise, effectively doubli…
Johnson & Johnson JNJ, a healthcare behemoth with a market cap exceeding $600 billion and a portfolio spanning pharmaceuticals and medical devices, has delivered a stellar year-to-date surge of approximately 24.5%. This performance notably outpaces the S&P 500's roughly 10% rise, effectively doubli…
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
